Health secretary Matt Hancock is planning to breathe new life into the government’s approach to prevention of ill health, with a shift in focus to primary and community services.
6th November 2018
Lilly says its once-weekly diabetes drug Trulicity cut major adverse cardiovascular events (MACE) in patients taking part in the REWIND trial.
6th November 2018
The Supreme Court has given its consent to the UK’s BioIndustry Association (BIA) to intervene in a case that the latter says “could have far-reaching impacts on the life sciences sector”.
6th November 2018
UK group Enesi Pharma has signed a deal with Australian biotech Sementis to develop solid dose versions of the latter’s lead peanut hypoallergy vaccine and its chikungunya/Zika vaccine candidates.
5th November 2018
Pfizer’s new lung cancer treatment Lorbrena has bagged US approval for previously treated patients with a specific gene mutation and metastatic disease.
5th November 2018
Novartis group Sandoz has decided not to pursue US submission of a biosimilar version of Roche's Rituxan/Mabthera, after a request from regulators for more data.
5th November 2018
Japanese drug giant Takeda has taken an exclusive license to Cambridge, UK-based Crescendo Biologics’ Humabodies directed to one of its oncology targets.
5th November 2018
All of the finalists competed in real life challenges that were devised by senior leaders in Sales. The contestants used their insightful knowledge and charisma in a bid to be announced as the winner on the 15th November.
5th November 2018
Designed to recognise and reward the talent and passion of industry and academic researchers, The PharmaTimes Clinical Researcher of the Year - The Americas is open to give contestants the ultimate challenge. A valuable learning and development opportunity for clinical researchers in pharma, clinical research organisations (CROs) and investigator sites who currently work in North, South and Central America.
5th November 2018
US regulators have approved MSD’s Keytruda, in combination with carboplatin and either paclitaxel or nab-paclitaxel, for the first-line treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC).
2nd November 2018
The British Heart Foundation is urging people with heart and circulatory disease to get vaccinated against the flu.
2nd November 2018
GlaxoSmithKline has reported long-term safety data showing a sustained reduction in severe asthma attacks and improved asthma control in patients taking its biologic Nucala.
2nd November 2018
All of the finalists competed in real life challenges that were devised by senior Marketing leaders. The contestants used their insightful knowledge and charisma in a bid to be announced as the winner(s) on the 15th November.
2nd November 2018
Alkermes’ ALKS 5461 has been hit with a potential setback in the US after regulatory advisors failed to back its approval for major depressive disorder (MDD).
2nd November 2018
